Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 2, 2004

Circulation. 2004
Published online before print February 2, 2004, doi: 10.1161/01.CIR.0000116762.77804.FC
A more recent version of this article appeared on February 24, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/7/849    most recent
01.CIR.0000116762.77804.FCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudhuri, A.
Right arrow Articles by Dandona, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudhuri, A.
Right arrow Articles by Dandona, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrow Coagulation and fibronolysis
Right arrow Coronary circulation
Right arrow Other Vascular biology

Submitted on September 16, 2003
Revised on November 7, 2003
Accepted on November 18, 2003

Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment-Elevation Myocardial Infarction

Ajay Chaudhuri MBBS, MRCP, David Janicke MD, PhD, Michael F. Wilson MD, Devjit Tripathy MD, Rajesh Garg MD, Arindam Bandyopadhyay MD, Janeen Calieri BSN, Debbie Hoffmeyer BS, Tufail Syed MBBS, Husam Ghanim MS, Ahmad Aljada PhD, and Paresh Dandona MD, PhD*

From the Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, and Kaleida Health (A.C., D.T., R.G., A.B., D.H., T.S., H.G., A.A., P.D.); Division of Cardiology, SUNY Buffalo, Kaleida Health (M.F.W.); MFHS Physicians Emergency Services, Department of Emergency Medicine, SUNY Buffalo (D.J.); and Department of Emergency Medicine, Kaleida Health (J.C.), Buffalo, NY.

* To whom correspondence should be addressed. E-mail: pdandona{at}kaleidahealth.org.

Background--The clinical benefits of insulin previously observed in acute ST-segment-elevation myocardial infarction (STEMI) may be partially explained by an anti-inflammatory effect. We assessed this potential effect of insulin in STEMI patients treated with fibrinolytics.

Methods and Results--Thirty-two patients receiving reteplase were randomly assigned infusions of either insulin at 2.5 U/h, dextrose, and potassium (GIK) or normal saline and potassium (C) for 48 hours. Plasma concentrations of high-sensitivity C-reactive protein (CRP), serum amyloid A (SAA), plasminogen activator inhibitor-1 (PAI-1), creatine kinase (CK), and CK-MB were measured at baseline and sequentially for 48 hours. Total p47phox protein in mononuclear cells was measured in a subgroup of 13 subjects. Baseline CRP and SAA were significantly increased (2- to 4-fold) at 24 and 48 hours in each group (P<0.01). However, in the insulin group, there was a significant (P<0.05) attenuation of the absolute rise in concentration of CRP and SAA from baseline. The absolute increase of CRP and SAA was reduced by 40% (CRP) and 50% (SAA) at 24 hours and at 48 hours compared with the control group. The absolute increase in PAI-1 from baseline and the percentage increase in p47phox over 48 hours were significantly (P<0.05) lower in the insulin-treated group. CK-MB peaked earlier and tended to be lower in insulin-treated subjects, especially in patients with inferior MI.

Conclusions--Insulin has an anti-inflammatory and profibrinolytic effect in patients with acute MI. These effects may contribute to the clinical benefits of insulin in STEMI.


Key words: myocardial infarction • inflammation • insulin • atherosclerosis




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. Marfella, C. Di Filippo, M. Portoghese, F. Ferraraccio, M. R. Rizzo, M. Siniscalchi, E. Musacchio, M. D'Amico, F. Rossi, and G. Paolisso
Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients
J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1425 - 1436.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Dandona, A. Chaudhuri, and H. Ghanim
Acute Myocardial Infarction, Hyperglycemia, and Insulin
J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1437 - 1439.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, F. A. Masoudi, A. Goyal, L. Xiao, P. G. Jones, S. Fiske, and J. A. Spertus
Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction
Arch Intern Med, March 9, 2009; 169(5): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty
Insulin as an anti-inflammatory and antiatherogenic modulator.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S14 - S20.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
M. Kosiborod
Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction
Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 269 - 275.
[Abstract] [PDF]


Home page
Diabetes CareHome page
H. Ghanim, P. Mohanty, R. Deopurkar, C. Ling Sia, K. Korzeniewski, S. Abuaysheh, A. Chaudhuri, and P. Dandona
Acute Modulation of Toll-Like Receptors by Insulin
Diabetes Care, September 1, 2008; 31(9): 1827 - 1831.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. Chao and J. H. Page
Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Am. J. Epidemiol., September 1, 2008; 168(5): 471 - 480.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. T. McCormick, K. W. Muir, C. S. Gray, and M. R. Walters
Management of Hyperglycemia in Acute Stroke: How, When, and for Whom?
Stroke, July 1, 2008; 39(7): 2177 - 2185.
[Full Text] [PDF]


Home page
JAMAHome page
A. Chaudhuri, R. Nesto, and P. Dandona
Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA, May 28, 2008; 299(20): 2386 - 2387.
[Full Text] [PDF]


Home page
CirculationHome page
R. A. Kloner and R. W. Nesto
Glucose-Insulin-Potassium for Acute Myocardial Infarction: Continuing Controversy Over Cardioprotection
Circulation, May 13, 2008; 117(19): 2523 - 2533.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Dickinson, D. P Hancock, P. Petocz, A. Ceriello, and J. Brand-Miller
High-glycemic index carbohydrate increases nuclear factor-{kappa}B activation in mononuclear cells of young, lean healthy subjects
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1188 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Hohberg, T. Forst, M. Larbig, M. Safinowski, S. Diessel, S. Hehenwarter, M. M. Weber, T. Schondorf, and A. Pfutzner
Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State
Diabetes Care, May 1, 2008; 31(5): 1021 - 1025.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. H. Opie
Metabolic Management of Acute Myocardial Infarction Comes to the Fore and Extends Beyond Control of Hyperglycemia
Circulation, April 29, 2008; 117(17): 2172 - 2177.
[Full Text] [PDF]


Home page
CirculationHome page
P. Deedwania, M. Kosiborod, E. Barrett, A. Ceriello, W. Isley, T. Mazzone, and P. Raskin
Hyperglycemia and Acute Coronary Syndrome: A Scientific Statement From the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism
Circulation, March 25, 2008; 117(12): 1610 - 1619.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
P. Dandona
Effects of Antidiabetic and Antihyperlipidemic Agents on C-Reactive Protein
Mayo Clin. Proc., March 1, 2008; 83(3): 333 - 342.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. W. Nesto and R. M. Lago
Glucose: A Biomarker in Acute Myocardial Infarction Ready for Prime Time?
Circulation, February 26, 2008; 117(8): 990 - 992.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Krogh-Madsen, P. Plomgaard, T. Akerstrom, K. Moller, O. Schmitz, and B. K. Pedersen
Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E371 - E379.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. M. Paravicini and R. M. Touyz
NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Chaudhuri, M. Miller, R. Nesto, N. Rosenberg, and P. Dandona
Targeting Glucose in Acute Myocardial Infarction: Has glucose, insulin, and potassium infusion missed the target?
Diabetes Care, December 1, 2007; 30(12): 3026 - 3028.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Gustafson, A. Hammarstedt, C. X. Andersson, and U. Smith
Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis
Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2276 - 2283.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
S. V Parikh, S. M Abdullah, E. C Keeley, J. E Cigarroa, T. A Addo, J. J Warner, A. Khera, J. A De Lemos, and D. K McGuire
Effect of glucose-insulin-potassium (GIK) infusion on biomarkers of cardiovascular risk in ST elevation myocardial infarction (STEMI): insight into the failure of GIK
Diabetes and Vascular Disease Research, September 1, 2007; 4(3): 222 - 225.
[Abstract] [PDF]


Home page
Diabetes CareHome page
H. Ghanim, P. Mohanty, R. Pathak, A. Chaudhuri, C. L. Sia, and P. Dandona
Orange Juice or Fructose Intake Does Not Induce Oxidative and Inflammatory Response
Diabetes Care, June 1, 2007; 30(6): 1406 - 1411.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. W. Zarich and R. W. Nesto
Implications and Treatment of Acute Hyperglycemia in the Setting of Acute Myocardial Infarction
Circulation, May 8, 2007; 115(18): e436 - e439.
[Full Text] [PDF]


Home page
NEJMHome page
S. E. Inzucchi
Management of Hyperglycemia in the Hospital Setting
N. Engl. J. Med., November 2, 2006; 355(18): 1903 - 1911.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H. B. Van Wezel
Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives.
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 224 - 227.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Walrand, C. Guillet, Y. Boirie, and M.-P. Vasson
Insulin Differentially Regulates Monocyte and Polymorphonuclear Neutrophil Functions in Healthy Young and Elderly Humans
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2738 - 2748.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. W. Cheung, V. W. Wong, and M. McLean
The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study: A randomized controlled trial of insulin infusion therapy for myocardial infarction
Diabetes Care, April 1, 2006; 29(4): 765 - 770.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Arimura, M. Li, V. Batuman, W.F. Clark, A.K. Stewart, G.A. Rock, M. Sternbach, D.M. Sutton, B.J. Barrett, A.P. Heidenheim, et al.
Cast Nephropathy in Myeloma--Does PACAP38, a New Member of the Vasoactive Intestinal Peptide Family, Open a Therapeutic Window?: Potential Protective Action of Pituitary Adenylate Cyclase-Activiating Polypeptide (PACAP38) on In Vitro and In Vivo Models of Myeloma Kidney Injury. Blood 107: 661-668, 2006
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 911 - 919.
[Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. R. Gosmanov, F. B. Stentz, and A. E. Kitabchi
De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E516 - E522.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. W. Quinn, D. Pagano, R. S. Bonser, S. J. Rooney, T. R. Graham, I. C. Wilson, B. E. Keogh, J. N. Townend, M. E. Lewis, P. Nightingale, et al.
Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: A randomized controlled trial
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 34 - 42.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Scognamiglio, C. Negut, S. V. de Kreutzenberg, A. Tiengo, and A. Avogaro
Effects of Different Insulin Regimes on Postprandial Myocardial Perfusion Defects in Type 2 Diabetic Patients
Diabetes Care, January 1, 2006; 29(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Garg, A. Chaudhuri, F. Munschauer, and P. Dandona
Hyperglycemia, Insulin, and Acute Ischemic Stroke: A Mechanistic Justification for a Trial of Insulin Infusion Therapy
Stroke, January 1, 2006; 37(1): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. W. Cheung, B. Napier, C. Zaccaria, and J. P. Fletcher
Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition
Diabetes Care, October 1, 2005; 28(10): 2367 - 2371.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
L. Visser, C. J. Zuurbier, F. J. Hoek, B. C. Opmeer, E. de Jonge, B. A. J. M. de Mol, and H. B. van Wezel
Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery
Br. J. Anaesth., October 1, 2005; 95(4): 448 - 457.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. F. Bonvini, T. Hendiri, and E. Camenzind
Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target?
Eur. Heart J. Suppl., October 1, 2005; 7(suppl_I): I27 - I36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wiggers, H. Norrelund, S. S. Nielsen, N. H. Andersen, J. E. Nielsen-Kudsk, J. S. Christiansen, T. T. Nielsen, N. Moller, and H. E. Botker
Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H938 - H946.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. S. Apstein and L. H. Opie
A challenge to the metabolic approach to myocardial ischaemia
Eur. Heart J., May 2, 2005; 26(10): 956 - 959.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg
Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation
Circulation, March 22, 2005; 111(11): 1448 - 1454.
[Full Text] [PDF]


Home page
Diabetes Spectr.Home page
C. L. Thompson, K. C. Dunn, M. C. Menon, L. E. Kearns, and S. S. Braithwaite
Hyperglycemia in the Hospital
Diabetes Spectr, January 1, 2005; 18(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. M. Choi, K. W. Lee, S. G. Kim, N. H. Kim, C. G. Park, H. S. Seo, D. J. Oh, D. S. Choi, and S. H. Baik
Inflammation, Insulin Resistance, and Glucose Intolerance in Acute Myocardial Infarction Patients without a Previous Diagnosis of Diabetes Mellitus
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 175 - 180.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. W. Wong, M. McLean, S. C. Boyages, and N. W. Cheung
C-Reactive Protein Levels Following Acute Myocardial Infarction: Effect of insulin infusion and tight glycemic control
Diabetes Care, December 1, 2004; 27(12): 2971 - 2973.
[Full Text] [PDF]


Home page
Diabetes CareHome page
A. Ceriello
Insulin, Glycemic Control, and C-Reactive Protein During Myocardial Infarction
Diabetes Care, December 1, 2004; 27(12): 3017 - 3018.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Dandona, A. Chaudhuri, and A. Aljada
The Relationship of Fasting Serum Radioimmune Insulin Levels to Incident Coronary Heart Disease in an Insulin-Treated Diabetic Cohort
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5868 - 5869.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Inpatient Diabetes Control: Approaches to treatment
Diabetes Care, September 1, 2004; 27(9): 2272 - 2277.
[Full Text] [PDF]


Home page
DiabetesHome page
F. B. Stentz, G. E. Umpierrez, R. Cuervo, and A. E. Kitabchi
Proinflammatory Cytokines, Markers of Cardiovascular Risks, Oxidative Stress, and Lipid Peroxidation in Patients With Hyperglycemic Crises
Diabetes, August 1, 2004; 53(8): 2079 - 2086.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Aljada, H. Ghanim, P. Mohanty, T. Syed, A. Bandyopadhyay, and P. Dandona
Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations
Am. J. Clinical Nutrition, July 1, 2004; 80(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
K. S Lewis, S. L Kane-Gill, M. B. Bobek, and J. F Dasta
Intensive Insulin Therapy for Critically Ill Patients
Ann. Pharmacother., July 1, 2004; 38(7): 1243 - 1251.
[Abstract] [Full Text] [PDF]